AGATA: First nationwide molecular screening program in Spain for patients with advanced breast cancer

ABSTRACT: The SOLTI-1301 AGATA study aimed to assess the feasibility of a multi-institutional molecular screening program to better characterize the genomic landscape of advanced breast cancer (ABC) and to facilitate patient access to matched-targeted therapies in Spain. Between September 2014 and July 2017, 305 patients with ABC from 10 institutions were enrolled.

ORGANISM(S): Homo sapiens

PROVIDER: GSE182852 | GEO | 2021/11/01

REPOSITORIES: GEO